12
Participants
Start Date
June 17, 2022
Primary Completion Date
September 16, 2022
Study Completion Date
September 16, 2022
PF-07284890 Treatment A
PF-07284890 tablet by mouth while fasting
PF-07284890 Treatment B
PF-07284890 tablet after low fat meal
PF-07284890 Treatment C
PF-07284890 tablet after high fat meal
New Haven Clinical Research Unit, New Haven
Lead Sponsor
Pfizer
INDUSTRY